SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bengalus who wrote (199)2/5/1999 5:25:00 AM
From: out_of_the_loop  Read Replies (1) of 5582
 
While 67 patients is not a huge study, p<.001 is nearly as impressive as it gets, so we will have to see the other study details. This number (1 in 1000) is quite a bit "more significant" than that which is generally considered "significant" (5 in 100). While it is way too early to judge without seeing the study, numbers such as these are precisely the kind that cause investigators to stop studies and just give patients the drug (in life-threatening diseases, not colds).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News